FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Wednesday introduced a new form to the Zyrtec portfolio of allergy-relief products — an oral, dissolvable tablet. Delivering the same effective 24-hour relief, Zyrtec Dissolve Tabs are now available at all major retailers and pharmacies.
Zyrtec, the best-selling brand within the cold-allergy-sinus tablet category, generated $317.3 million for the 52 weeks ended Dec. 29, up 1.8% across total U.S. multi-outlet, according to IRI data.
"Expanding the Zyrtec portfolio to include a dissolvable tab provides the brand an opportunity to reach children as well as the adult consumer who is sometimes caught off guard by their allergy symptoms," stated Colleen Sellers, group brand director, allergy at McNeil Consumer Healthcare. "Zyrtec Dissolve Tabs are ideal for 'on the go' situations because they can be taken anytime, anywhere without water."
The launch of the Zyrtec Dissolve Tabs will come to life through various marketing channels, including dedicated digital, television and radio advertising as well as retail activations. The advertising campaign will begin mid-March and will run nationally as well as in strategic regional markets, McNeil reported.